Several miRNAs, including miR-18a, miR-21, miR-26a, and miR-92a, negatively regulate PTEN expression across breast cancers, hepatocellular carcinoma, high-grade glioma, and colorectal cancers, respectively [13,14,15,16]. The gene discussed is PTEN; the disease is central nervous system cancer.